<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Konig SM</submitter><funding>ISCRA CINECA</funding><funding>Carlsbergfondet</funding><funding>Danmarks Grundforskningsfond</funding><funding>LEO Foundation</funding><funding>Novo Nordisk Foundation Center for Protein Research</funding><funding>Partnership for Advanced Computing in Europe AISBL</funding><funding>LEO Fondet</funding><pagination>e1007485</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6927658</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(12)</volume><pubmed_abstract>Apoptosis is an essential defensive mechanism against tumorigenesis. Proteins of the B-cell lymphoma-2 (Bcl-2) family regulate programmed cell death by the mitochondrial apoptosis pathway. In response to intracellular stress, the apoptotic balance is governed by interactions of three distinct subgroups of proteins; the activator/sensitizer BH3 (Bcl-2 homology 3)-only proteins, the pro-survival, and the pro-apoptotic executioner proteins. Changes in expression levels, stability, and functional impairment of pro-survival proteins can lead to an imbalance in tissue homeostasis. Their overexpression or hyperactivation can result in oncogenic effects. Pro-survival Bcl-2 family members carry out their function by binding the BH3 short linear motif of pro-apoptotic proteins in a modular way, crea</pubmed_abstract><journal>PLoS computational biology</journal><pubmed_title>Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.</pubmed_title><pmcid>PMC6927658</pmcid><funding_grant_id>DNRF125</funding_grant_id><funding_grant_id>PI Søren Brunak</funding_grant_id><funding_grant_id>CF18-0314</funding_grant_id><funding_grant_id>P10C8YXRK</funding_grant_id><funding_grant_id>HP10CBLBWO</funding_grant_id><funding_grant_id>DECI-15th</funding_grant_id><funding_grant_id>DECI-14th</funding_grant_id><funding_grant_id>LF17006</funding_grant_id><pubmed_authors>Lambrughi M</pubmed_authors><pubmed_authors>Konig SM</pubmed_authors><pubmed_authors>Rissler V</pubmed_authors><pubmed_authors>Terkelsen T</pubmed_authors><pubmed_authors>Papaleo E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.</name><description>Apoptosis is an essential defensive mechanism against tumorigenesis. Proteins of the B-cell lymphoma-2 (Bcl-2) family regulate programmed cell death by the mitochondrial apoptosis pathway. In response to intracellular stress, the apoptotic balance is governed by interactions of three distinct subgroups of proteins; the activator/sensitizer BH3 (Bcl-2 homology 3)-only proteins, the pro-survival, and the pro-apoptotic executioner proteins. Changes in expression levels, stability, and functional impairment of pro-survival proteins can lead to an imbalance in tissue homeostasis. Their overexpression or hyperactivation can result in oncogenic effects. Pro-survival Bcl-2 family members carry out their function by binding the BH3 short linear motif of pro-apoptotic proteins in a modular way, crea</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2026-05-04T09:23:03.153Z</modification><creation>2020-05-22T07:18:01Z</creation></dates><accession>S-EPMC6927658</accession><cross_references><pubmed>31825969</pubmed><doi>10.1371/journal.pcbi.1007485</doi></cross_references></HashMap>